Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion type Assertion NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_head.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_provenance.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion evidence source_evidence_literature NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_provenance.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion SIO_000772 22660274 NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_provenance.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion wasDerivedFrom befree-2016 NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_provenance.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion wasGeneratedBy ECO_0000203 NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_provenance.